Peripheral neuropathic pain
Information
- Disease name
- Peripheral neuropathic pain
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05890053 | Active, not recruiting | Phase 3 | To Evaluate the Long-term Safety and Efficacy of HSK16149 in Chinese Patients With Peripheral Neuralgia | February 17, 2022 | August 7, 2023 |
| NCT01524796 | Completed | NEP-TUNE: Neuropathic Pain - Treatment With Pregabalin Under Real-life Conditions in Denmark | January 2012 | March 2014 | |
| NCT01737294 | Completed | Observation of the Use of QUTENZA™ in Standard Clinical Practice | February 2012 | August 2014 | |
| NCT02100046 | Completed | Phase 2 | Assessment of the Effectiveness of Ethosuximide in the Treatment of Peripheral Neuropathic Pain. | March 2014 | January 1, 2017 |
| NCT02209896 | Completed | N/A | BlueWind Reprieve System for the Treatment of PNP | December 2014 | March 2017 |
| NCT02985216 | Completed | Phase 3 | Clinical Trial of YHD1119 in Patients With Peripheral Neuropathic Pain | February 7, 2017 | May 2, 2018 |
| NCT03009500 | Completed | Phase 3 | Randomized Controlled Trial of Efficacy and Safety of Local Anesthetics and Steroids for Chronic Peripheral Post-traumatic Neuropathic Pain | January 2017 | June 2019 |
| NCT03191136 | Completed | Phase 1 | Clinical Trial to Assess the Effect of Food on the Pharmacokinetics of YHD1119 in Healthy Volunteers | May 10, 2017 | October 30, 2017 |
| NCT03733886 | Completed | N/A | Burst Spinal Cord Stimulation for Neuropathic Pain. | September 9, 2019 | June 22, 2023 |
| NCT06234917 | Completed | N/A | Increasing Sensori-Motor Rhythm Activity by EEG-Neurofeedback to Reduce the Impact of Pain on Daily Functioning | January 4, 2021 | February 1, 2023 |
| NCT04494815 | Completed | Phase 1/Phase 2 | A Phase 1b Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SR419 | September 18, 2020 | July 31, 2022 |
| NCT05219812 | Completed | Phase 2 | A Study to Learn How Safe BAY2395840 is and How Well it Works in Participants Who Have Diabetic Nerve Pain | February 16, 2022 | November 21, 2022 |
| NCT05416931 | Completed | Phase 2 | ACD440 Gel in Peripheral Neuropathic Pain | June 20, 2022 | March 10, 2023 |
| NCT01240148 | Completed | Phase 1 | Determine the Effect of AZD3161,Injected Intradermally, on Quantitative Sensory Testing Variables in Normal and Ultraviolet-C (UVC) Exposed Skin in Healthy Volunteers | December 2010 | March 2011 |
| NCT04431778 | Recruiting | Phase 2 | Evaluation of the Efficacy and Tolerance of Low Doses of Ethosuximide in the Treatment of Peripheral Neuropathic Pain | November 1, 2020 | December 31, 2023 |
| NCT05817591 | Recruiting | Response Profiles to High-concentration Capsaicin Desensitization in Patients With Peripheral Neuropathic Pain With or Without Allodynia: a Regional Multicenter Prospective Cohort | December 14, 2023 | June 15, 2026 | |
| NCT01293851 | Terminated | Molecular-Genetic Mechanisms Associated With Chemotherapy-Induced Nerve Damage | December 22, 2010 | November 13, 2012 | |
| NCT04171453 | Unknown status | Post-marketing Surveillance (PMS) to Observe the Safety and Effectiveness of Lyrica CR Extended Release Tablets | February 3, 2020 | July 14, 2022 |